Home Synthego

Synthego

acquired
Series E
Gene Engineering Solutions Provider
Basic
Enterprise Profile

Basic Information

Synthego is a supplier of genetic engineering solutions dedicated to accelerating life science research and development to improve human health. The company leverages machine learning, automation, and gene editing to build scientific platforms on a large scale. With its foundation in engineering disciplines, the company’s platform technology vertically integrates proprietary hardware, software, bioinformatics, chemistry, and molecular biology to advance basic research, target validation, and clinical trials. Its flagship product, CRISPRevolution, is a series of synthetic RNA products used in CRISPR gene editing and research-designed experiments, aimed at improving the efficiency of gene editing experiments and reducing experimental costs.
Synthego Corp
California,United States of America
101~500 people
July 01, 2012
info@synthego.com

Enterprise Profile

Industrial Sector
Biomanufacturing New Drug Development Immune Cell Therapy Gene Therapy Production of Genetically Engineered Drugs
Technology
Biotechnology Genetic Engineering Gene Editing
Concept
Disease Treatment Department of Pharmacy
Application Scenarios
Innovative Drugs Cell and Gene Therapy AI+Pharmaceuticals TCR-T